-
Patient PerspectivesSurviving with heart failure
Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.
Patient Perspectives -
Access to HealthcareHealth collaboration in Russia helped reduce blood pressure, deaths
Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.
Access to Healthcare -
From Our LabsFixing what’s lost in translation
From Our Labs -
DiscoveryCould umbilical cords yield more stem cells for life-saving transplants?
Umbilical cords are a potentially life-saving source of blood stem cells for people with leukemia and other diseases. But there aren’t enough cells to meet demand. Now an experimental treatment offers hope for a solution.
Discovery -
From Our LabsLetters to my younger self: Female scientists share their wisdom
Accomplished female scientists at Novartis share their wisdom born from difficult moments in life.
From Our Labs -
From Our LabsNurturing the life science ecosystem
From Our Labs -
DiscoveryHow a love of sport led to a scientific breakthrough
Jeff Weers’ passion inspired a new way of getting inhaled medicine past the body’s natural defenses to reach the lungs.
Discovery -
From Our LabsCancer spies find drug-beating covert cells
From Our Labs -
DiscoveryNew recruit has big dreams for cancer immunotherapy
Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
Discovery -
Patient PerspectivesPsoriasis: The story of a hidden condition
More than 125 million people worldwide live with psoriasis, a chronic autoimmune disease that causes red, scaly patches to appear on the skin.
Patient Perspectives -
From Our LabsTurning up the heat on tumors
From Our Labs -
From Our LabsVision hacker
Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
From Our Labs